Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
© 2022 ZHANG et al..
Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated children, which is much lower than in unvaccinated adults, remains unexplained. In an international cohort of 112 children (<16 yr old) hospitalized for COVID-19 pneumonia, we report 12 children (10.7%) aged 1.5-13 yr with critical (7 children), severe (3), and moderate (2) pneumonia and 4 of the 15 known clinically recessive and biochemically complete inborn errors of type I IFN immunity: X-linked recessive TLR7 deficiency (7 children) and autosomal recessive IFNAR1 (1), STAT2 (1), or TYK2 (3) deficiencies. Fibroblasts deficient for IFNAR1, STAT2, or TYK2 are highly vulnerable to SARS-CoV-2. These 15 deficiencies were not found in 1,224 children and adults with benign SARS-CoV-2 infection without pneumonia (P = 1.2 × 10-11) and with overlapping age, sex, consanguinity, and ethnicity characteristics. Recessive complete deficiencies of type I IFN immunity may underlie ∼10% of hospitalizations for COVID-19 pneumonia in children.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:219 |
---|---|
Enthalten in: |
The Journal of experimental medicine - 219(2022), 8 vom: 01. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Qian [VerfasserIn] |
---|
Links: |
---|
Themen: |
Interferon Type I |
---|
Anmerkungen: |
Date Completed 20.06.2022 Date Revised 16.05.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1084/jem.20220131 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM342299956 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM342299956 | ||
003 | DE-627 | ||
005 | 20231226013801.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1084/jem.20220131 |2 doi | |
028 | 5 | 2 | |a pubmed24n1140.xml |
035 | |a (DE-627)NLM342299956 | ||
035 | |a (NLM)35708626 | ||
035 | |a (PII)e20220131 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Qian |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.06.2022 | ||
500 | |a Date Revised 16.05.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 ZHANG et al. | ||
520 | |a Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated children, which is much lower than in unvaccinated adults, remains unexplained. In an international cohort of 112 children (<16 yr old) hospitalized for COVID-19 pneumonia, we report 12 children (10.7%) aged 1.5-13 yr with critical (7 children), severe (3), and moderate (2) pneumonia and 4 of the 15 known clinically recessive and biochemically complete inborn errors of type I IFN immunity: X-linked recessive TLR7 deficiency (7 children) and autosomal recessive IFNAR1 (1), STAT2 (1), or TYK2 (3) deficiencies. Fibroblasts deficient for IFNAR1, STAT2, or TYK2 are highly vulnerable to SARS-CoV-2. These 15 deficiencies were not found in 1,224 children and adults with benign SARS-CoV-2 infection without pneumonia (P = 1.2 × 10-11) and with overlapping age, sex, consanguinity, and ethnicity characteristics. Recessive complete deficiencies of type I IFN immunity may underlie ∼10% of hospitalizations for COVID-19 pneumonia in children | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, N.I.H., Intramural | |
650 | 7 | |a Interferon Type I |2 NLM | |
700 | 1 | |a Matuozzo, Daniela |e verfasserin |4 aut | |
700 | 1 | |a Le Pen, Jérémie |e verfasserin |4 aut | |
700 | 1 | |a Lee, Danyel |e verfasserin |4 aut | |
700 | 1 | |a Moens, Leen |e verfasserin |4 aut | |
700 | 1 | |a Asano, Takaki |e verfasserin |4 aut | |
700 | 1 | |a Bohlen, Jonathan |e verfasserin |4 aut | |
700 | 1 | |a Liu, Zhiyong |e verfasserin |4 aut | |
700 | 1 | |a Moncada-Velez, Marcela |e verfasserin |4 aut | |
700 | 1 | |a Kendir-Demirkol, Yasemin |e verfasserin |4 aut | |
700 | 1 | |a Jing, Huie |e verfasserin |4 aut | |
700 | 1 | |a Bizien, Lucy |e verfasserin |4 aut | |
700 | 1 | |a Marchal, Astrid |e verfasserin |4 aut | |
700 | 1 | |a Abolhassani, Hassan |e verfasserin |4 aut | |
700 | 1 | |a Delafontaine, Selket |e verfasserin |4 aut | |
700 | 1 | |a Bucciol, Giorgia |e verfasserin |4 aut | |
700 | 0 | |a COVID Human Genetic Effort |e verfasserin |4 aut | |
700 | 1 | |a Bayhan, Gulsum Ical |e verfasserin |4 aut | |
700 | 1 | |a Keles, Sevgi |e verfasserin |4 aut | |
700 | 1 | |a Kiykim, Ayca |e verfasserin |4 aut | |
700 | 1 | |a Hancerli, Selda |e verfasserin |4 aut | |
700 | 1 | |a Haerynck, Filomeen |e verfasserin |4 aut | |
700 | 1 | |a Florkin, Benoit |e verfasserin |4 aut | |
700 | 1 | |a Hatipoglu, Nevin |e verfasserin |4 aut | |
700 | 1 | |a Ozcelik, Tayfun |e verfasserin |4 aut | |
700 | 1 | |a Morelle, Guillaume |e verfasserin |4 aut | |
700 | 1 | |a Zatz, Mayana |e verfasserin |4 aut | |
700 | 1 | |a Ng, Lisa F P |e verfasserin |4 aut | |
700 | 1 | |a Lye, David Chien |e verfasserin |4 aut | |
700 | 1 | |a Young, Barnaby Edward |e verfasserin |4 aut | |
700 | 1 | |a Leo, Yee-Sin |e verfasserin |4 aut | |
700 | 1 | |a Dalgard, Clifton L |e verfasserin |4 aut | |
700 | 1 | |a Lifton, Richard P |e verfasserin |4 aut | |
700 | 1 | |a Renia, Laurent |e verfasserin |4 aut | |
700 | 1 | |a Meyts, Isabelle |e verfasserin |4 aut | |
700 | 1 | |a Jouanguy, Emmanuelle |e verfasserin |4 aut | |
700 | 1 | |a Hammarström, Lennart |e verfasserin |4 aut | |
700 | 1 | |a Pan-Hammarström, Qiang |e verfasserin |4 aut | |
700 | 1 | |a Boisson, Bertrand |e verfasserin |4 aut | |
700 | 1 | |a Bastard, Paul |e verfasserin |4 aut | |
700 | 1 | |a Su, Helen C |e verfasserin |4 aut | |
700 | 1 | |a Boisson-Dupuis, Stéphanie |e verfasserin |4 aut | |
700 | 1 | |a Abel, Laurent |e verfasserin |4 aut | |
700 | 1 | |a Rice, Charles M |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Shen-Ying |e verfasserin |4 aut | |
700 | 1 | |a Cobat, Aurélie |e verfasserin |4 aut | |
700 | 1 | |a Casanova, Jean-Laurent |e verfasserin |4 aut | |
700 | 1 | |a Abel, Laurent |e investigator |4 oth | |
700 | 1 | |a Abolhassani, Hassan |e investigator |4 oth | |
700 | 1 | |a Aiuti, Alessandro |e investigator |4 oth | |
700 | 1 | |a Akcan, Ozge Metin |e investigator |4 oth | |
700 | 1 | |a Al-Muhsen, Saleh |e investigator |4 oth | |
700 | 1 | |a Al-Mulla, Fahd |e investigator |4 oth | |
700 | 1 | |a Alkan, Gulsum |e investigator |4 oth | |
700 | 1 | |a Anderson, Mark S |e investigator |4 oth | |
700 | 1 | |a Andreakos, Evangelos |e investigator |4 oth | |
700 | 1 | |a Arias, Andrés A |e investigator |4 oth | |
700 | 1 | |a El Bakkouri, Jalila |e investigator |4 oth | |
700 | 1 | |a Baris Feldman, Hagit |e investigator |4 oth | |
700 | 1 | |a Belot, Alexandre |e investigator |4 oth | |
700 | 1 | |a Biggs, Catherine M |e investigator |4 oth | |
700 | 1 | |a Bogunovic, Dusan |e investigator |4 oth | |
700 | 1 | |a Bolze, Alexandre |e investigator |4 oth | |
700 | 1 | |a Bondarenko, Anastasiia |e investigator |4 oth | |
700 | 1 | |a Bousfiha, Ahmed A |e investigator |4 oth | |
700 | 1 | |a Bozdemir, Sefika Elmas |e investigator |4 oth | |
700 | 1 | |a Brodin, Petter |e investigator |4 oth | |
700 | 1 | |a Bryceson, Yenan |e investigator |4 oth | |
700 | 1 | |a Bustamante, Carlos D |e investigator |4 oth | |
700 | 1 | |a Butte, Manish J |e investigator |4 oth | |
700 | 1 | |a Casari, Giorgio |e investigator |4 oth | |
700 | 1 | |a Christodoulou, John |e investigator |4 oth | |
700 | 1 | |a Colobran, Roger |e investigator |4 oth | |
700 | 1 | |a Condino-Neto, Antonio |e investigator |4 oth | |
700 | 1 | |a Constantinescu, Stefan N |e investigator |4 oth | |
700 | 1 | |a Cooper, Megan A |e investigator |4 oth | |
700 | 1 | |a Dalgard, Clifton L |e investigator |4 oth | |
700 | 1 | |a Desai, Murkesh |e investigator |4 oth | |
700 | 1 | |a Drolet, Beth A |e investigator |4 oth | |
700 | 1 | |a El Baghdadi, Jamila |e investigator |4 oth | |
700 | 1 | |a Emiroglu, Melike |e investigator |4 oth | |
700 | 1 | |a Erdeniz, Emine Hafize |e investigator |4 oth | |
700 | 1 | |a Espinosa-Padilla, Sara |e investigator |4 oth | |
700 | 1 | |a Fellay, Jacques |e investigator |4 oth | |
700 | 1 | |a Flores, Carlos |e investigator |4 oth | |
700 | 1 | |a Franco, José Luis |e investigator |4 oth | |
700 | 1 | |a Froidure, Antoine |e investigator |4 oth | |
700 | 1 | |a Gregersen, Peter K |e investigator |4 oth | |
700 | 1 | |a Grimbacher, Bodo |e investigator |4 oth | |
700 | 1 | |a Gulhan, Belgin |e investigator |4 oth | |
700 | 1 | |a Haerynck, Filomeen |e investigator |4 oth | |
700 | 1 | |a Hagin, David |e investigator |4 oth | |
700 | 1 | |a Halwani, Rabih |e investigator |4 oth | |
700 | 1 | |a Hammarström, Lennart |e investigator |4 oth | |
700 | 1 | |a Heath, James R |e investigator |4 oth | |
700 | 1 | |a Henrickson, Sarah E |e investigator |4 oth | |
700 | 1 | |a Hsieh, Elena W Y |e investigator |4 oth | |
700 | 1 | |a Husebye, Eystein |e investigator |4 oth | |
700 | 1 | |a Imai, Kohsuke |e investigator |4 oth | |
700 | 1 | |a Itan, Yuval |e investigator |4 oth | |
700 | 1 | |a Jabandziev, Petr |e investigator |4 oth | |
700 | 1 | |a Jarvis, Erich D |e investigator |4 oth | |
700 | 1 | |a Karamitros, Timokratis |e investigator |4 oth | |
700 | 1 | |a Karbuz, Adem |e investigator |4 oth | |
700 | 1 | |a Kisand, Kai |e investigator |4 oth | |
700 | 1 | |a Ku, Cheng-Lung |e investigator |4 oth | |
700 | 1 | |a Lau, Yu-Lung |e investigator |4 oth | |
700 | 1 | |a Ling, Yun |e investigator |4 oth | |
700 | 1 | |a Lucas, Carrie L |e investigator |4 oth | |
700 | 1 | |a Maniatis, Tom |e investigator |4 oth | |
700 | 1 | |a Mansouri, Davood |e investigator |4 oth | |
700 | 1 | |a Maródi, László |e investigator |4 oth | |
700 | 1 | |a Metin, Ayse |e investigator |4 oth | |
700 | 1 | |a Meyts, Isabelle |e investigator |4 oth | |
700 | 1 | |a Milner, Joshua D |e investigator |4 oth | |
700 | 1 | |a Mironska, Kristina |e investigator |4 oth | |
700 | 1 | |a Mogensen, Trine H |e investigator |4 oth | |
700 | 1 | |a Morio, Tomohiro |e investigator |4 oth | |
700 | 1 | |a Ng, Lisa F P |e investigator |4 oth | |
700 | 1 | |a Notarangelo, Luigi D |e investigator |4 oth | |
700 | 1 | |a Novelli, Antonio |e investigator |4 oth | |
700 | 1 | |a Novelli, Giuseppe |e investigator |4 oth | |
700 | 1 | |a O'Farrelly, Cliona |e investigator |4 oth | |
700 | 1 | |a Okada, Satoshi |e investigator |4 oth | |
700 | 1 | |a Okamoto, Keisuke |e investigator |4 oth | |
700 | 1 | |a Tüter Öz, Şadiye Kübra |e investigator |4 oth | |
700 | 1 | |a Ozcelik, Tayfun |e investigator |4 oth | |
700 | 1 | |a Pan-Hammarström, Qiang |e investigator |4 oth | |
700 | 1 | |a Papadaki, Maria |e investigator |4 oth | |
700 | 1 | |a Pape, Jean W |e investigator |4 oth | |
700 | 1 | |a Parlakay, Aslinur Ozkaya |e investigator |4 oth | |
700 | 1 | |a Perez de Diego, Rebeca |e investigator |4 oth | |
700 | 1 | |a Perlin, David S |e investigator |4 oth | |
700 | 1 | |a Pesole, Graziano |e investigator |4 oth | |
700 | 1 | |a Planas, Anna M |e investigator |4 oth | |
700 | 1 | |a Pokorna, Petra |e investigator |4 oth | |
700 | 1 | |a Prando, Carolina |e investigator |4 oth | |
700 | 1 | |a Pujol, Aurora |e investigator |4 oth | |
700 | 1 | |a Quintana-Murci, Lluis |e investigator |4 oth | |
700 | 1 | |a Ramaswamy, Sathishkumar |e investigator |4 oth | |
700 | 1 | |a Renia, Laurent |e investigator |4 oth | |
700 | 1 | |a Resnick, Igor |e investigator |4 oth | |
700 | 1 | |a Rivière, Jacques G |e investigator |4 oth | |
700 | 1 | |a Rodríguez-Gallego, Carlos |e investigator |4 oth | |
700 | 1 | |a Sancho-Shimizu, Vanessa |e investigator |4 oth | |
700 | 1 | |a Sediva, Anna |e investigator |4 oth | |
700 | 1 | |a Seppänen, Mikko R J |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The Journal of experimental medicine |d 1896 |g 219(2022), 8 vom: 01. Aug. |w (DE-627)NLM000005967 |x 1540-9538 |7 nnns |
773 | 1 | 8 | |g volume:219 |g year:2022 |g number:8 |g day:01 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.1084/jem.20220131 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 219 |j 2022 |e 8 |b 01 |c 08 |